This topic contains a solution. Click here to go to the answer

Author Question: If an overpayment is received from a government agency, the provider must report the reason for ... (Read 60 times)

rl

  • Hero Member
  • *****
  • Posts: 579
If an overpayment is received from a government agency, the provider must report the reason for overpayment and return the money within
 A) 30 days.
  B) 45 days.
  C) 60 days.
  D) 90 days.

Question 2

When calling an insurance company to verify a patient's coverage or to obtain an authorization, which of the following must you have on hand?
 A) Copy of the front and back of the patient's insurance card
  B) The patient's complete chart
  C) Copy of the patient's medical history and any transferred records
  D) The patient's signed registration form



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

C

Answer to Question 2

A




rl

  • Member
  • Posts: 579
Reply 2 on: Jun 25, 2018
:D TYSM


kusterl

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

More than 30% of American adults, and about 12% of children utilize health care approaches that were developed outside of conventional medicine.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library